Long‐lasting residual efficacy of Actellic® 300CS and Icon® 10CS on different surfaces against Anopheles stephensi , an invasive malaria vector
Tropical Medicine & International Health · 2024
DOI: 10.1111/tmi.14028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2024. Verfasst von Fatemeh Nikpour und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Anopheles, Insecticides, Mosquito Control, Mosquito Vectors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
Anopheles stephensi , a malaria‐transmitting mosquito species, has developed resistance to various insecticides such as DDT, Dieldrin, Malathion, and synthetic pyrethroids. To combat this issue, the World Health Organization (WHO) suggests using Actellic®300CS and Icon®10CS for Indoor Residual Spraying to tackle pyrethroid‐resistant mosquitoes. The aim of this research project was to evaluate the susceptibility of An . stephensi to certain insecticides at the diagnostic concentration + intensity 5x diagnostic concentration (5XDC) assays in Iran and to study the lasting effectiveness of Actellic®300CS and Icon®10CS against this particular malaria vector.
Methods
This study assessed the susceptibility of An . stephensi populations in southern Iran to various insecticides, including deltamethrin 0.05%, DDT 4%, malathion 5%, bendiocarb 0.1%, a synergist assay with PBO 4% combined with deltamethrin 0.05%, and an intensity assay using 5x the diagnostic concentration of deltamethrin (0.25%) and bendiocarb 0.5%. Laboratory cone bioassay tests were conducted to determine the residual effectiveness of Actellic®300 and Icon®10CS insecticides on different surfaces commonly found in households, such as cement, mud, plaster, and wood. The tests were carried out following the WHO test kits and standard testing protocols.
Results
The An . stephensi populations in Bandar Abbas were found to be susceptible to malathion 5% and deltamethrin 0.25% (5XDC), but exhibited resistance to DDT, standard concentration of deltamethrin, and both standard and intensity concentrations of bendiocarb. In laboratory cone bioassay tests, An . stephensi mortality rates when exposed to Actellic®300CS and Icon®10CS on different surfaces remained consistently more than 80%. Actellic®300CS achieved more than 80% mortality on all substrates for the entire 300‐day post‐spraying period. Conversely, Icon®10CS maintained mortality rates more than 80% on plaster and wood surfaces for 165 days and on mud and cement surfaces for 270 days post‐spraying. Both Actellic®300CS and Icon®10CS demonstrated 100% mortality within 72 h of each test on all surfaces throughout the entire 300‐day post‐spraying period.
Conclusion
The study shows the varying levels of resistance of An . stephensi Bandar Abbas population to different insecticides and demonstrates the consistent performance of Actellic®300CS in controlling these mosquitoes on various surfaces. The findings suggest that long‐lasting CS formulations may be more effective for malaria vector control compared to the current options. Further research is needed to validate these findings in field settings and assess the impact of these insecticides on malaria transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Environmental Research, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Vector-Borne Diseases, Centre for Communicable Diseases Control, Ministry of Health, Tehran, Iran.
- Department of Vector Biology & Control of Diseases, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Deputy of Health, Hormozgan University of Medical Sciences, Tehran, Iran.
- Department of Medical Parasitology & Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Fatemeh Nikpour, Madineh Abbasi
Zitieren
APA
Nikpour, F., Vatandoost, H., Hanafi-Bojd, A. A., Raeisi, A., Mirolyaie, A., Mojahedi, A. R., Yaryan, M., Banar, A., Kaveh, F., Abbasi, M., & Farmani, M. (2024). Long‐lasting residual efficacy of Actellic® 300CS and Icon® 10CS on different surfaces against Anopheles stephensi , an invasive malaria vector. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.14028
Vancouver
Nikpour F, Vatandoost H, Hanafi-Bojd AA, Raeisi A, Mirolyaie A, Mojahedi AR, et al. Long‐lasting residual efficacy of Actellic® 300CS and Icon® 10CS on different surfaces against Anopheles stephensi , an invasive malaria vector. Tropical Medicine & International Health. 2024. doi:10.1111/tmi.14028
BibTeX
@article{Nikpour2024,
author = {Nikpour, Fatemeh and Vatandoost, Hassan and Hanafi-Bojd, Ahmad Ali and Raeisi, Ahmad and Mirolyaie, Abdolreza and Mojahedi, Abdol-Rasol and Yaryan, Masoud and Banar, Ahad and Kaveh, Farzad and Abbasi, Madineh and Farmani, Mostafa},
title = {Long‐lasting residual efficacy of Actellic® 300CS and Icon® 10CS on different surfaces against Anopheles stephensi , an invasive malaria vector},
journal = {Tropical Medicine & International Health},
year = {2024},
doi = {10.1111/tmi.14028}
}
EUVIMED